471 Results (Page 1 of 19)
Canada Markets Research Reports
Canada Dental Service Market Analysis
Canada Dental Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Dental Services is expanding as a result of increasing oral diseases like dental caries, periodontal diseases and oral cancer. Increasing demand for cosmetic dentistry, dental implants and oral diseases are fueling the Dental Service Market. Some of the key players in the global Dental Service Market are Smile 360, Pacific Dental Services, Dental Services Group, Axiss Dental, Q & M Dental Group, Apollo White Dental, Coast Dental, Gentle Dental of New England, Abano Healthcare Group, Healthway Medical Corporation.
Canada In Vitro Fertilization (IVF) Service Market Analysis
In Vitro Fertilization (IVF) is a complex assisted reproductive technology (ART) designed to facilitate conception by fertilizing an egg outside the body. The procedure starts with ovarian stimulation to produce multiple eggs, which are then collected and mixed with sperm in a lab. Once fertilization occurs, the resulting embryo is transferred into the woman's uterus in hopes of achieving pregnancy. IVF is typically pursued when other fertility treatments have failed or when specific fertility issues, such as blocked fallopian tubes, endometriosis, or low sperm count, are present.
Canada Cancer Pain Management Market Analysis
Canada's Cancer Pain Management market is projected to grow from $521.6 Mn in 2022 to $788.43 Mn by 2030, registering a CAGR of 5.3 % during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in cancer cases, advancements in pain management technologies and treatment, and government support and initiatives. The market is segmented by drug type and by disease. Some of the major players include WEX Pharmaceuticals (CAN), Tetra Bio-Pharma (CAN), Pfizer, Teva Pharmaceuticals, and Medtronic.
Canada Dilated Cardiomyopathy Therapeutics Market Analysis
Canada Dilated Cardiomyopathy Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The phrase "dilated cardiomyopathy" refers to conditions that affect the heart muscle and is regarded as a deadly cardiac condition. Reduced myocardial contractility and left and right ventricular dilatation are usually its defining characteristics. The potential driving force behind the DCM Therapeutics Market has been the rise in diagnostic alterations and symptom awareness, as well as declining dietary and lifestyle choices that have led to an increase in the occurrence of disease. The government is sponsoring research and development (R&D) projects to encourage scientists and pharmaceutical firms to create novel treatments. Array BioPharma, Inc., AstraZeneca plc, Celladon Corporation, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. (J&J), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Vericel Corporation, and many others are key players in the market for cystic fibrosis (CF) therapeutics.
Canada Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Canada Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Canada Mucopolysaccharidosis I (MPS-I) Therapeutics Market Analysis
Canada Mucopolysaccharidosis I (MPS-I) therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Rising consumer awareness, new drug approvals, enticing reimbursement plans, an established healthcare system, and the presence of sizable market competitors all drive the market for treating Mucopolysaccharidosis I. Major global players in this market are Takeda Pharmaceutical Company Limited, BioMarin Pharmaceuticals, Inc., Ultragenyx Pharmaceutical Inc., Sarepta Therapeutics, Abeona Therapeutics, Eloxx Pharmaceuticals, Esteve, Immusoft Corporation, Inventiva, GC Pharma, JCR Pharmaceuticals Co Ltd., RegenxBio Inc., Sangamo Therapeutics, Inc., Bioasis Technologies Inc., and Paradigm Biopharmaceuticals Ltd.
Canada Spinal Muscular Atrophy (SMA) Therapeutics Market Analysis
Canada Spinal Muscular Atrophy (SMA) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market is expanding as a result of rising SMA instances, technological advancements, government encouragement, rising consumer awareness, and increased R&D activities. Major global players in Spinal Muscular Atrophy (SMA) Therapeutics Market are Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Boehringer Ingelheim International GmbH. (Germany), GSK plc (U.K.), Novartis AG (Switzerland), Biogen (U.S.), Pfizer Inc.(U.S.), Ionis Pharmaceuticals, Inc. (U.S.), Regeneron Pharmaceuticals Inc (U.S.)., Abbott (U.S.), AbbVie Inc. (U.S.), Novo Nordisk A/S (Denmark), Takeda Pharmaceutical Company Limited (Japan), AstraZeneca (U.K.), Leadiant Biosciences, Inc.(Italy), Catalyst Pharmaceuticals, Inc.(U.S.), PTC Therapeutics (U.S.)
Canada PET Scan Market Analysis
The Canada PET Scan Market was valued at $155.2 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $224.3 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the Canada PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
Canada Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Canada Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Canada Adrenoleukodystrophy (ALD) drugs market.
Canada Electronic Health Records Market Analysis
The Canada Electronic Health Records market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4% from 2022 to 2030 and will reach $3.09 Bn in 2030. Canada's EHR market growth can be attributed to the surging need for remote monitoring and chronic disease management. The market is segmented by product type, application type, and end user. The key market players are Allscripts, Cerner, Epic Systems, and others.
Canada Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Canada Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 4.8 % from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is increase in awareness, aging population. The market is segmented by diagnostic method, by treatment, by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, Calliditas Therapeutics among others.
Canada Primary Hyperoxaluria (PH) Therapeutics Market Analysis
Canada Primary Hyperoxaluria (PH) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. One of the key factors propelling the growth of the hyperoxaluria drug market is the rise in the number of persons with the condition worldwide. The regulatory body's extension of special designations and rising consumer demand for medications including thiazide diuretics, calcium oxalate urinary inhibitors, and others to address a variety of health issues both contribute to the market's quick growth. Major global players in Primary Hyperoxaluria (PH) Therapeutics Market are Allena Pharmaceuticals, Inc., Intellia Therapeutics, Inc., OxThera, Dicerna Pharmaceuticals, Inc, Alnylam Pharmaceuticals, Inc., Pfizer Inc., and Sanofi.
Canada Dermatological Therapeutics Market Analysis
Canada Dermatological Therapeutics Market is at around $3.28 Bn in 2023 and is projected to reach $5.84 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is growing due to factors such as the rising prevalence of skin disorders, the aging population, and technological developments. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.
Canada Dental Caries Detectors Market Analysis
The Canada Dental Caries Detectors Market was valued at $18.3 Mn in 2023 and is predicted to grow at a CAGR of 8.9% from 2023 to 2030, to $33.2 Mn by 2030. Canada Dental Caries Detectors Market is growing due to Lifestyle changes, Rising awareness, and Advanced imaging and diagnostic. The market is primarily dominated by players such as Dentalcorp Holdings Ltd., 123Dentist, Altima Dental Canada Holdings Inc.Sirona Dental Systems, Dentsply Sirona, KaVo Kerr, Ivoclar Vivadent, Planmeca Oy, Adec Technologies, 3M ESPE, Morita Corporation.
Canada Clinical Nutrition for Diabetes Care Market Analysis
The Canada Clinical Nutrition for Diabetes Care Market was valued at $172 Mn in 2023 and is predicted to grow at a CAGR of 4.78% from 2023 to 2030, to $238.49 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Abbott Nutrition, Eli Lily, Danone, AgaMatrix Inc., and among others.
Canada Pharmacy Automation Device Market Analysis
The Canada Pharmacy Automation Device Market was valued at $440 Mn in 2023 and is predicted to grow at a CAGR of 9.9% from 2023 to 2030, to $852 Mn by 2030. Canada Pharmacy Automation Device Market is growing due to Adoption of Electronic Health Records, Reducing Human Errors, and Rising Demand for Pharmaceuticals. The market is primarily dominated by players such as Amerisource Bergen Corporation, Accu-Chart Plus Healthcare Systems, Omnicell, Inc., McKesson Corporation; Pearson Medical Technologies, Baxter; Talyst, LLC, Scriptpro LLC.
Canada Biosensors Market Analysis
The Canada Biosensors Market was valued at $2312 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $3962.4 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, technological advancements, and growing demand for Point-of-Care (POC) testing. The prominent players of the Canada Biosensors Market are Nicoya Lifesciences, SomaDetect, Biosensors International, Nix Biosensors, Nova Biomedical Corporation, and Abbott Laboratories, among others.
Canada Clinical Nutrition Market Analysis
The Canada Clinical Nutrition Market was valued at $2453.6 Mn in 2023 and is projected to grow at a CAGR of 5.34% from 2023 to 2023, to $3531.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Vicore Pharma Holding, Cambrooke Therapeutics, Abbott Nutrition, Bayer AG, Nestle among others.
Canada Oculopharyngeal Muscular Dystrophy (OPMD) Market Analysis
Canada Oculopharyngeal Muscular Dystrophy (OPMD) market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Oculopharyngeal Muscular Dystrophy (OPMD)is growing due to increase spending in research and development activities by pharmaceutical companies, incentives provided by regulatory authorities like orphan drug designations and accelerated approval pathways, patient support and advocacy programmes which help to increase awareness about disease and provide support to patients. Bristol-Myers Squibb, BioMarin, Sarepta Therapeutics, Benitec Biopharma Inc., Bioblast Pharma, PTC Therapeutics, NS Pharma, Nobelpharma Co., Ltd ,Santhera Pharmaceuticals, Pfizer Inc. ,Marathon Pharmaceuticals, Fibrogen, GSK are the key global market players.
Canada Mental Health Apps Market Analysis
The Canada Mental Health Apps Market was valued at $496 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $1335.52 Mn by 2030. The key drivers of this industry include rising awareness, advancement in technology, and increasing smartphone penetration. The industry is primarily dominated by players such as Pocketwell, PTSD Coach Canada, Hope, TELUS Health MyCare, and Mindshift among others.
Canada Cardiac Pacemakers Market Analysis
The Canada Cardiac Pacemakers Market was valued at $323.75 Mn in 2023 and is predicted to grow at a CAGR of 3.20% from 2023 to 2030, to $403.62 Mn by 2030. The key drivers of this industry include an aging population, the prevalence of cardiovascular disease, and technological advancements. The industry is primarily dominated by players such as Abbott Laboratories, Biotronik, Boston Scientific, and Medtronic among others.
Canada Clinical Nutrition for Cancer Care Market Analysis
The Canada Clinical Nutrition for Cancer Care Market was valued at $450.4 Mn in 2023 and is predicted to grow at a CAGR of 5.04% from 2023 to 2030, to $635.5 Mn by 2030. The key drivers of the market include the increasing prevalence of cancer, increased awareness and education, and increasing healthcare expenditure. The prominent players of the Canada Clinical Nutrition for Cancer Care Market are Nestlé Health Science, Abbott Nutrition, B. Braun Melsungen AG, Pfizer, and Fresenius Kabi, among others.
Canada Gram-Negative Infection Therapeutics Market Analysis
The Canada Gram-Negative Infection Therapeutics Market was valued at $1190.08 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030 to $1777.5 Mn by 2030. Market dynamics are driven by the increasing incidence of infections, unmet medical needs, and favourable government initiatives. Leading companies in this market include AstraZeneca and Johnson & Johnson, among others.
Canada Home Infusion Therapy Market
The Canada Home Infusion Therapy Market was valued at $2876.8 Mn in 2023 and is predicted to grow at a CAGR of 8.1% from 2023 to 2030, to $4962.4 Mn by 2030. The key drivers of the market include rising prevalence of chronic diseases, expanding geriatric population, and technological advancements. The prominent players of the Canada Home Infusion Therapy Market are Option Care Health, Baxter International, ICU Medical (Smiths Medical), Becton, Dickinson and Company (BD), and Fresenius Kabi, among others.
Canada Hepatitis A Therapeutics Market Analysis
The Canada Hepatitis A Therapeutics Market valued at $58.98 Mn in 2023, projected to reach $68.68 Mn by 2030 with a CAGR of 2.2%. Key industry drivers encompass increasing prevalence, inadequate personal hygiene and sanitation facilities, and government initiatives. Leading companies in this sector include GlaxoSmithKline (GSK) and Sanofi, among others.